Show simple item record

dc.contributor.authorO'Connell, K
dc.contributor.authorBoo, T W
dc.contributor.authorKeady, D
dc.contributor.authorNiriain, U
dc.contributor.authorO'Donovan, D
dc.contributor.authorCommane, M
dc.contributor.authorFaherty, C
dc.contributor.authorCormican, M
dc.date.accessioned2011-07-20T11:14:56Z
dc.date.available2011-07-20T11:14:56Z
dc.date.issued2011-04
dc.identifier.citationUse of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction. 2011, 77 (4):338-42 J. Hosp. Infect.en
dc.identifier.issn1532-2939
dc.identifier.pmid21330007
dc.identifier.doi10.1016/j.jhin.2010.12.012
dc.identifier.urihttp://hdl.handle.net/10147/136381
dc.description.abstractRespiratory syncytial virus (RSV) is a potentially life-threatening infection in premature infants. We report an outbreak involving four infants in the neonatal intensive care unit (NICU) of our hospital that occurred in February 2010. RSV A infection was confirmed by real-time polymerase chain reaction. Palivizumab was administered to all infants in the NICU. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross-transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management.
dc.language.isoenen
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/21330007en
dc.subject.meshAntibodies, Monoclonal
dc.subject.meshAntiviral Agents
dc.subject.meshCross Infection
dc.subject.meshDNA, Viral
dc.subject.meshDisease Outbreaks
dc.subject.meshFemale
dc.subject.meshGenotype
dc.subject.meshHumans
dc.subject.meshInfant
dc.subject.meshInfant, Newborn
dc.subject.meshInfection Control
dc.subject.meshIntensive Care, Neonatal
dc.subject.meshPolymerase Chain Reaction
dc.subject.meshRespiratory Syncytial Virus Infections
dc.subject.meshRespiratory Syncytial Virus, Human
dc.titleUse of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction.en
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Microbiology, University College Hospital, Galway, Ireland. karinaoconnell@gmail.comen
dc.identifier.journalThe Journal of hospital infectionen
dc.description.provinceConnacht
html.description.abstractRespiratory syncytial virus (RSV) is a potentially life-threatening infection in premature infants. We report an outbreak involving four infants in the neonatal intensive care unit (NICU) of our hospital that occurred in February 2010. RSV A infection was confirmed by real-time polymerase chain reaction. Palivizumab was administered to all infants in the NICU. There were no additional symptomatic cases and repeat RSV surveillance confirmed that there was no further cross-transmission within the unit. The outbreak highlighted the infection control challenge of very high bed occupancy in the unit and the usefulness of molecular methods in facilitating detection and management.


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record